Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1983-12-05
1985-07-16
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 90, A61K 31535, C07D49804
Patent
active
045297223
ABSTRACT:
A 7.beta.-ureidoacetamido-7.alpha.-methoxy-3-[1-(2-hydroxyethyl)-1H-tetrazol -5-yl]thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid derivative represented by the following formula: ##STR1## wherein R is aryl or heteroaryl; R.sup.1 is hydrogen or alkyl optionally substituted by halogen or pyridinium; R.sup.2 is hydrogen or a hydroxy-protecting group; and R.sup.3 is hydrogen, a light metal, or a carboxy-protecting group.
REFERENCES:
patent: 4013653 (1977-03-01), Wolfe
patent: 4232151 (1980-11-01), Nagata et al.
patent: 4371532 (1983-02-01), Narisada et al.
Cama et al., J. Am. Chem. Soc., 96:24, Nov. 27, 1974, pp. 7582-7584.
Narisada et al., J. Med. Chem., vol. 22, No. 7, Jul. 1979, pp. 757-759.
Wolfe et al., Can. J. Chem., vol. 52, (1974), pp. 3996-3999.
Matsumura Hiromu
Narisada Masayuki
Yano Toshisada
Raymond Richard L.
Shionogi & Co. Ltd.
LandOfFree
Oxacephalosporin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxacephalosporin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxacephalosporin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1736463